BiotechTube
Home/Pipeline/Coronary Stent

Coronary Stent

Coronary artery disease

ApprovedActive

Key Facts

Indication
Coronary artery disease
Phase
Approved
Status
Active
Company
Advanced Biomed

About Advanced Biomed

Advanced Biomed is a commercial-stage medical device company headquartered in Taipei, Taiwan. It specializes in stents and catheters for cardiovascular and interventional procedures. Little public information is available about its pipeline, funding, or leadership, but it appears to operate in the competitive interventional cardiology market with a focus on accessible, cost-effective devices for Asian and emerging markets.

View full company profile

Therapeutic Areas

CardiovascularInterventional

Other Coronary artery disease Drugs

DrugCompanyPhase
MUTI™ Drug‑Eluting StentMerilCommercial
Coronary Artery Bypass GraftsVascudynePre-clinical
Premier DESRelisys Medical DevicesCommercial
Release R DESRelisys Medical DevicesCommercial
Pristine DESRelisys Medical DevicesCommercial
BioMatrix family (Flex/Alpha)Biosensors InternationalCommercial
Coronary Artery Disease ProgramElixir MedicalPre-clinical
Essential pro StentiVascularUPost-Market
FGF-1Zhittya Genesis MedicinePhase 2
OMT-28OMEICOS TherapeuticsPhase 2
Fantom EncoreREVA MedicalCommercial
Next-Gen Drug-Eluting StentsTransluminaDevelopment